ASC is attracting private equity investment in many markets — here are five key notes on PE and ASCs in 2023:
Patsy Newitt
The year 2024 is around the corner and ASCs are employing several strategies to prepare for growth.
While demand for anesthesia services has skyrocketed, Medicare reimbursements have shrunk, according to VMG Health's 2023 "Physician Alignment: Tips & Trends" report.
Private equity remains a strong force in physician practice deals, according to VMG Health's 2023 "Physician Alignment: Tips & Trends" report.
ASCs were overwhelmed by anesthesiologist shortages and anesthesia price hikes in 2023.
More than 40% of physicians said they would "likely" or "definitely" reduce clinical work hours in the next year, according to data published in November in Mayo Clinic Proceedings.
Sen. Elizabeth Warren of Massachusetts and Sen. Richard Blumenthal of Connecticut are calling for U.S. Anesthesia Partners and its private equity partner Welsh, Carson, Anderson & Stowe to answer for what a federal agency called an "anticompetitive scheme."
A Louisiana man has been charged in connection with a $148 million Medicare and Medicaid fraud scheme that involved physician kickbacks from January 2013 to around August 2022.
ASC leaders are becoming increasingly frustrated with the reimbursement disparity between hospital outpatient departments and surgery centers.
Optum, the largest employer of physicians in the country, has doubled down on its physician acquisition strategy in 2023.
